Amiko develops advanced sensor technologies and AI-enabled mobile health solutions to assist healthcare professionals and empower patients to achieve better outcomes.
The first company worldwide that markets truly personalized nutritional supplements based on recurring, pain-free blood sampling at home.
Biotechnology company developing a unique oral device for delivery of biologics that would otherwise be injected.
CogniScent combines clinically validated testing with data-driven insights to support a timely diagnosis and self-management of neurodegenerative diseases, such as Parkinson’s and Alzheimer’s. CogniScent is a business angel investment by our managing director Jürgen Sanner.
The digital health solution Kata® by Vision Health utilizes a combination of machine learning and augmented reality to enhance chronic pulmonary disease self-management as well as to bridge the communication and training gap between patients, physicians and providers.
OnDosis is developing a game changing drug delivery platform for personalized and connected dosing of medicines with the objective to improve treatment outcomes for a wide array of diseases and patients. Its proprietary technology delivers flexible and individualised dosing of oral medicines formulated as micro units such as granules and multiparticulates.